Skip to main content
. 2016 Aug 24;49(2):494–501. doi: 10.4143/crt.2016.129

Table 3.

Germ cell tumor male-female incidence rate ratio, 2005-2012

Primary site Total
Male
Female
Male to female rate ratio (95% CI)
Count, n (%) ASRa) Count, n (%) ASRa) Count, n (%) ASRa)
Pineal (C753) 226 (34.6) 0.06 211 (42.0) 0.11 15 (10.0) 0.01 13.62 (9.15-20.28)
Nonpineal (C700-729, 751-752) 428 (65.4) 0.12 293 (58.1) 0.15 135 (90.0) 0.08 1.87 (1.54-2.28)
 Suprasellar region (C715, 719, 729, 751) 317 (48.5) 0.09 204 (40.5) 0.11 113 (75.3) 0.07 1.55 (1.23-1.94)
  Ventricle (C715) 43 (6.6) 0.01 35 (6.9) 0.02 8 (5.3) 0.01 3.52 (1.78-6.97)
  Brain, NOS (C719) 229 (35.0) 0.06 145 (28.8) 0.08 84 (56.0) 0.05 1.46 (1.12-1.91)
  Nervous system, NOS (C729) 1 (0.2) 0.00 1 (0.2) 0.00 0 0.00 0.00 (0.00-0.00)
  Pituitary gland (C751) 44 (6.7) 0.01 23 (4.6) 0.01 21 (14.0) 0.01 0.99 (0.54-1.79)
 Cerebrum (C710) 62 (9.5) 0.02 53 (10.5) 0.03 9 (6.0) 0.01 5.45 (2.94-10.09)
 All other sites 49 (7.5) 0.01 36 (7.1) 0.02 13 (8.7) 0.01 2.31 (1.27-4.20)
All germ cell tumors 654 (100.0) 0.18 504 (100.0) 0.26 150 (100.0) 0.09 2.95 (2.49-3.49)

ASR, age-standardized rate; CI, confidence interval; NOS, not otherwise specified.

a)

Adjusted with the year 2000 United States standard population.